114 related articles for article (PubMed ID: 31780963)
1. Kundalini Yoga Meditation Versus the Relaxation Response Meditation for Treating Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Shannahoff-Khalsa D; Fernandes RY; Pereira CAB; March JS; Leckman JF; Golshan S; Vieira MSR; Polanczyk GV; Miguel EC; Shavitt RG
Front Psychiatry; 2019; 10():793. PubMed ID: 31780963
[No Abstract] [Full Text] [Related]
2. Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial.
Foa EB; Simpson HB; Gallagher T; Wheaton MG; Gershkovich M; Schmidt AB; Huppert JD; Imms P; Campeas RB; Cahill S; DiChiara C; Tsao SD; Puliafico A; Chazin D; Asnaani A; Moore K; Tyler J; Steinman SA; Sanches-LaCay A; Capaldi S; Snorrason Í; Turk-Karan E; Vermes D; Kalanthroff E; Pinto A; Hamlett GE; Middleton R; Hahn CG; Xu B; Van Meter PE; Katechis M; Rosenfield D
JAMA Psychiatry; 2022 Mar; 79(3):193-200. PubMed ID: 35080598
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of transcranial direct current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder: a randomized, double-blind, sham-controlled, clinical trial.
Yoosefee S; Amanat M; Salehi M; Mousavi SV; Behzadmanesh J; Safary V; Yoonesi A; Salehi B
BMC Psychiatry; 2020 Nov; 20(1):570. PubMed ID: 33256659
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study.
Rostami R; Kazemi R; Jabbari A; Madani AS; Rostami H; Taherpour MA; Molavi P; Jaafari N; Kuo MF; Vicario CM; Nitsche MA; Salehinejad MA
BMC Psychiatry; 2020 Jul; 20(1):372. PubMed ID: 32677923
[TBL] [Abstract][Full Text] [Related]
5. Benefits of stereotactic radiosurgical anterior capsulotomy for obsessive-compulsive disorder: a meta-analysis.
Gupta R; Chen JW; Hughes NC; Hamo M; Jean-Baptiste S; Paulo DL; Chanbour H; Fan R; Ye F; Vadali A; Cmelak A; Bick SK
J Neurosurg; 2024 Mar; ():1-12. PubMed ID: 38552242
[TBL] [Abstract][Full Text] [Related]
6. Agomelatine efficacy in treatment resistant obsessive-compulsive disorder: A randomized double-blind clinical trial.
Nejati A; Bazrafshan A; Mosavat SH
Int J Psychiatry Med; 2023 Dec; ():912174231225763. PubMed ID: 38156645
[TBL] [Abstract][Full Text] [Related]
7. Serotonin 3 receptor antagonists for obsessive-compulsive disorder: A systematic review and pairwise meta-analysis.
Hamanaka S; Kishi T; Sakuma K; Nishii Y; Hatano M; Iwata N
J Psychiatr Res; 2023 Nov; 167():132-138. PubMed ID: 37866327
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of unguided self-help psychological interventions for obsessive-compulsive disorder: A meta-analysis of randomized controlled trials.
Wang Y; Amarnath A; Miguel C; Ciharova M; Lin J; Zhao R; Struijs SY; de Wit LM; Toffolo MBJ; Cuijpers P
Compr Psychiatry; 2024 Apr; 130():152453. PubMed ID: 38290294
[TBL] [Abstract][Full Text] [Related]
9. Exposure and response prevention versus stress management training for adults and adolescents with obsessive compulsive disorder: A randomized clinical trial.
Himle JA; Grogan-Kaylor A; Hiller MA; Mannella KA; Norman LJ; Abelson JL; Prout A; Shunnarah AA; Becker HC; Russman Block SR; Taylor SF; Fitzgerald KD
Behav Res Ther; 2024 Jan; 172():104458. PubMed ID: 38103359
[TBL] [Abstract][Full Text] [Related]
10. Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.
Ching THW; Amoroso L; Bohner C; D'Amico E; Eilbott J; Entezar T; Fitzpatrick M; Fram G; Grazioplene R; Hokanson J; Kichuk SA; Martins B; Patel P; Schaer H; Shnayder S; Witherow C; Pittenger C; Kelmendi B
Front Psychiatry; 2023; 14():1278823. PubMed ID: 38264632
[TBL] [Abstract][Full Text] [Related]
11. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder - A non-inferiority randomized controlled trial.
Exner C; Kleiman A; Haberkamp A; Hansmeier J; Milde C; Glombiewski JA
J Anxiety Disord; 2024 Jun; 104():102873. PubMed ID: 38729024
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of treatment response and remission definitions in adult obsessive-compulsive disorder: A systematic review and individual-patient data meta-analysis.
Ramakrishnan D; Farhat LC; Vattimo EFQ; Levine JLS; Johnson JA; Artukoglu BB; Landeros-Weisenberger A; Zangen A; Pelissolo A; de B Pereira CA; Rück C; Costa DLC; Mataix-Cols D; Shannahoff-Khalsa D; Tolin DF; Zarean E; Meyer E; Hawken ER; Storch EA; Andersson E; Miguel EC; Maina G; Leckman JF; Sarris J; March JS; Diniz JB; Kobak K; Mallet L; Vulink NCC; Amiaz R; Fernandes RY; Shavitt RG; Wilhelm S; Golshan S; Tezenas du Montcel S; Erzegovesi S; Baruah U; Greenberg WM; Kobayashi Y; Bloch MH
J Psychiatr Res; 2024 May; 173():387-397. PubMed ID: 38598877
[TBL] [Abstract][Full Text] [Related]
13. Reboxetine Combination Therapy With Fluoxetine in Moderate to Severe Obsessive-Compulsive Disorder: A Placebo-Controlled, Double-Blind, Randomized Trial.
Tilaki EH; Hasanzadeh A; Shalbafan M; Moghaddam HS; Shamabadi A; Boroon M; Akhondzadeh S
Clin Neuropharmacol; 2023 Sep-Oct 01; 46(5):175-180. PubMed ID: 37747999
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Disease Severity, Anxiety and Depression in Obsessive-Compulsive Disorder Patients with Different Insight.
Zhu C; Huang Y; Zhu W; Jiang X; Liang Y; Tang W; Xu Z
Actas Esp Psiquiatr; 2024 Feb; 52(1):10-18. PubMed ID: 38454899
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of acceptance and commitment therapy in treating a case of obsessive compulsive disorder.
Vakili Y; Gharraee B
Iran J Psychiatry; 2014 Apr; 9(2):115-7. PubMed ID: 25632289
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.
Khalkhali M; Aram S; Zarrabi H; Kafie M; Heidarzadeh A
Iran J Psychiatry; 2016 Apr; 11(2):104-14. PubMed ID: 27437007
[TBL] [Abstract][Full Text] [Related]
17. Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy.
Kaltenboeck A; Foerster E; Strafner S; Demal U; Mossaheb N; Friedrich F
Front Psychiatry; 2023; 14():1291077. PubMed ID: 38090708
[TBL] [Abstract][Full Text] [Related]
18. A pilot open trial of video telehealth-delivered exposure and response prevention for obsessive-compulsive disorder in rural Veterans.
Fletcher TL; Boykin DM; Helm A; Dawson DB; Ecker AH; Freshour J; Teng E; Lindsay J; Hundt NE
Mil Psychol; 2022; 34(1):83-90. PubMed ID: 38536285
[TBL] [Abstract][Full Text] [Related]
19. Perceived Stress in Obsessive-Compulsive Disorder is Related with Obsessive but Not Compulsive Symptoms.
Morgado P; Freitas D; Bessa JM; Sousa N; Cerqueira JJ
Front Psychiatry; 2013; 4():21. PubMed ID: 23565098
[TBL] [Abstract][Full Text] [Related]
20. Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder.
Vakili Y; Gharaee B; Habibi M
Iran J Psychiatry Behav Sci; 2015 Jun; 9(2):e845. PubMed ID: 26288647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
